Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as a lyophilized powder for solution for injection for subcutaneous use. It treats female infertility due to anovulation, supports controlled ovarian stimulation for assisted reproductive technologies, and may be used in male infertility as part of combination therapy.

GNH USA supplies Menopur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menopur (menotropin) is used in reproductive hormone therapy to stimulate follicular development and ovulation. - Female infertility due to anovulation: induces follicular growth to enable ovulation. - Controlled ovarian stimulation for assisted reproductive technologies (e.g., IVF): supports multiple follicle development for egg retrieval. - Male infertility (as part of combination therapy): provides LH activity to stimulate testosterone production and spermatogenesis.

Menopur may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site reactions: redness, swelling, or pain at the injection site. - Mild ovarian hyperstimulation syndrome: abdominal discomfort and bloating. - Headache: mild to moderate intensity. - Nausea: occasional feeling of queasiness. - Mood changes: irritability or emotional lability.

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome: rapid weight gain, shortness of breath, electrolyte imbalance. - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Allergic reactions: rash, urticaria, anaphylaxis.

When using Menopur, clinicians should observe several safety measures. - Individualize dosing: adjust based on ovarian response monitored by ultrasound and hormone levels. - Monitor for ovarian hyperstimulation syndrome: watch for abdominal pain, rapid weight gain, or shortness of breath. - Avoid use in uncontrolled thyroid disease: correct thyroid function before initiating therapy. - Use caution in patients with estrogen‑dependent tumors: assess risk versus benefit. - Pregnancy testing: confirm non‑pregnant status before starting treatment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medications that affect hormonal balance or coagulation.

Major Interactions (Avoid): - GnRH agonists used for down‑regulation: may exacerbate ovarian hyperstimulation if not properly timed. - High‑dose estrogen therapy: can blunt response to menotropin. - Anticoagulants (e.g., warfarin): increased risk of ovarian hemorrhage.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: monitor thyroid function as menotropin can affect hormone levels. - Corticosteroids: may alter ovarian response, requiring monitoring. - Insulin or oral hypoglycemics: watch for changes in glucose control during ovarian stimulation.